Ahmad SamerAl-HomsiMDMBA

Hematology • New York, NY

Hematologic Oncology

Professor of Medicine NYU Grossman School of Medicine Director, Blood and Marrow Transplantation NYU Langone Health

Join to view full profile

Dr. Al-Homsi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Al-Homsi's full profile

Already have an account?

Office
240 East 38th Street
19th Floor
New York, NY 10016
Phone+1 646-501-4848

Fax+1 212-263-9701

Education & Training

UMass Chan Medical SchoolFellowship, Hematology and Medical Oncology, 1995 - 1998
Advocate Health Care/Advocate Christ Medical CenterResidency, Internal Medicine, 1992 - 1995
Damascus University Faculty of MedicineClass of 1984

Certifications & Licensure

NY State Medical License 2017 - 2026
MD State Medical License 2017 - 2020
MI State Medical License 2013 - 2020
MA State Medical License 1995 - 2019
RI State Medical License 2008 - 2014

Clinical Trials

High-Dose Post-Transplant Cyclophosphamide and Bortezomib (CyBor) for the Prevention of Graft-versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Start of enrollment: 2019 Jun 20
Completed
Phase 2

Publications & Presentations

PubMed

27 citations
Post-transplantation Cyclophosphamide: From HLA-Haploidentical to Matched-Related and Matched-Unrelated Donor Blood and Marrow Transplantation.
Louis Williams, Frank Cirrone, Kelli Cole, Maher Abdul-Hay, Leo Luznik
Frontiers in Immunology. 2020-04-09
77 citations
Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transpla...
Mohamed A. Kharfan-Dabaja, Ambuj Kumar, Ernesto Ayala, Mahmoud Aljurf, Taiga Nishihori
Transplantation and Cellular Therapy. 2021-08-01
39 citations
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant Cyclophosphamide.
Annie Im, Armin Rashidi, Tao Wang, Michael T. Hemmer, Margaret L. MacMillan
Biology of Blood and Marrow Transplantation. 2019-03-01

Press Mentions

Shop TalkMay 25th, 2017
Al-Homsi to Lead New Bone Marrow Transplantation Program at NYU LangoneMay 3rd, 2017
Hematologist-Oncologist to Lead Innovative NYU Bone Marrow Transplant InitiativeApril 17th, 2017
Join now to see all